Organization – Page 20

Moderna Terminates Gene Editing Partnership, Shifts Focus to mRNA Technology

1 year ago talkbio0Tagged biobucks, Biotechnology, deal termination, Gene Modification, Metagenomi, Moderna, mRNA technology, Partnership

Moderna, Metagenomi, gene editing, partnership, mRNA technology, biotechnology, biobucks, deal termination

Editas Medicine and Bristol Myers Squibb Expand T Cell Therapy Collaboration; KalVista Pharmaceuticals Seeks Partnership for Preclinical Hereditary Angioedema Program

1 year ago talkbio0Tagged Angioedemas, Hereditary, Collaboration, Editas Medicine, KalVista, Myers, Partnership, preclinical program, squibb, T cell therapy

Editas Medicine, Bristol Myers Squibb, T cell therapy, collaboration, KalVista Pharmaceuticals, preclinical program, hereditary angioedema (HAE), partnership.

Novartis Invests $180M in PeptiDream to Boost Radiopharmaceutical Development

1 year ago talkbio0Tagged Cancer Therapeutic Procedure, cellular targeting, Drug Development, Investments, Isotopes, Novartis, Partnership, PeptiDream, Radioactivity, Radiopharmaceuticals

Novartis, PeptiDream, radiopharmaceuticals, investment, drug development, partnership, targeted therapies, cancer treatment, radioactive isotopes.

BMS Collaborates to Revolutionize Immunotherapy: The Repertoire Vaccine Partnership

1 year ago talkbio0Tagged Bristol Myers Squibb, Burning Mouth Syndrome, Cancer Therapeutic Procedure, immune system reset, Immunotherapy, Partnership, Precision Medicine, Repertoire, Vaccines

BMS, Bristol-Myers Squibb, Repertoire, immunotherapy, vaccine, immune system reset, partnership, cancer treatment, personalized medicine.

Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

1 year ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, development aspects, Gene Modification, Genetic Research, Health care facility, Mammoth Biosciences, Partnership, Regeneron

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.

Novartis to Revise CRO Partnerships Amidst US Senate Bill Scrutiny

1 year ago talkbio0Tagged Chinese Language, CRO, Drug Industry, Novartis, Partnership, regulatory, Relationships, Revisions, Senate

Novartis, CRO relationships, US Senate bill, Chinese companies, pharmaceutical industry, regulatory changes, partnership revisions

FDA Greenlights UTILITY’s Innovative Antibiotic for Simple Urinary Tract Infections in Women

1 year ago talkbio0Tagged Antibiotics, Approved, United States Food and Drug Administration, Urinary tract infection, UTI, Utilities (organization), Woman

FDA, UTILITY, antibiotic, uncomplicated UTI, women, approval, innovative, treatment, urinary tract infection

Strategic Acquisition, Partnership, and Development of Innovative Assets in Biopharma

1 year ago talkbio0Tagged Acquisition (action), Biopharma, development aspects, Drug Development, Drug Industry, innovative assets, Market, Partnership, Portfolio diversification, Risk Management, strategic decision-making, trends qualifier

Biopharma, Innovative Assets, Acquisition, Partnership, Development, Strategic Decision-Making, Pharmaceutical Industry, Drug Development, Market Trends, Risk Management, Portfolio Diversification